Comparison of Mirabegron and Imidafenacin for efficacy and safety in Japanese female patients with overactive bladder: A randomized controlled trial (COMFORT Study)
Phase of Trial: Phase IV
Latest Information Update: 01 Dec 2016
Price : $35 *
At a glance
- Drugs Mirabegron (Primary) ; Imidafenacin
- Indications Overactive bladder
- Focus Therapeutic Use
- Acronyms COMFORT
- 26 Sep 2016 Status changed from active, no longer recruiting to completed.
- 12 May 2015 Planned End Date changed to 31 Mar 2015 as reported by University Hospital Medical Information Network - Japan record.
- 27 Mar 2015 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan record.